Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Hypertension Associated With Interstitial Lung Disease”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableAvailableNCT06939647
What this trial is testing

An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension, Interstitial Lung Disease
Insmed Incorporated
Testing effectiveness (Phase 2)WithdrawnNCT00323024
What this trial is testing

Dose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
NITROX, LLC 72
Testing effectiveness (Phase 2)Study completedNCT03727451
What this trial is testing

A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis

Who this might be right for
Pulmonary HypertensionPulmonary FibrosisSarcoidosis, Pulmonary
Bellerophon 17
Testing effectiveness (Phase 2)Looking for participantsNCT07333183
What this trial is testing

Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease (ILD)Lung Diseases+3 more
Pulmovant, Inc. 20
Large-scale testing (Phase 3)WithdrawnNCT03726398
What this trial is testing

CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PH

Who this might be right for
Interstitial Lung DiseaseSclerodermaPulmonary Hypertension
Franz Rischard, DO
Testing effectiveness (Phase 2)UnknownNCT05747508
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon 85
Testing effectiveness (Phase 2)WithdrawnNCT02603068
What this trial is testing

Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary HypertensionPulmonary Fibrosis
United Therapeutics
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Large-scale testing (Phase 3)Ended earlyNCT00879229
What this trial is testing

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Hypertension
Gilead Sciences 40
Large-scale testing (Phase 3)Ended earlyNCT03267108
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon Pulse Technologies 145
Not applicableStudy completedNCT05703802
What this trial is testing

Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

Who this might be right for
SepsisPre-EclampsiaGranulomatosis With Polyangiitis+4 more
University Hospital Muenster 30
Not applicableLooking for participantsNCT06388421
What this trial is testing

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Due to Lung Diseases and HypoxiaPulmonary HypertensionInterstitial Lung Disease
United Therapeutics 900
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07441278
What this trial is testing

A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NS Pharma, Inc. 177
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Testing effectiveness (Phase 2)Looking for participantsNCT06475781
What this trial is testing

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward)

Who this might be right for
Group 3 Pulmonary Hypertension
Foresee Pharmaceuticals Co., Ltd. 126
Not applicableAvailableNCT05356052
What this trial is testing

Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon
Testing effectiveness (Phase 2)Looking for participantsNCT07175038
What this trial is testing

ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension, Interstitial Lung Disease
AllRock Bio, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00694850
What this trial is testing

Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)

Who this might be right for
Hypertension, Pulmonary
Bayer 22
Large-scale testing (Phase 3)Study completedNCT05649722
What this trial is testing

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Who this might be right for
Pulmonary HypertensionInterstitial Lung Disease
Insmed Incorporated 31
Not applicableStudy completedNCT00820729
What this trial is testing

Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseasePulmonary HypertensionBiomarkers
University of Aarhus 212
Next Page